Dr. Sydney Montesi, MD
Claim this profileMassachusetts General Hospital
Area of expertise
Idiopathic Pulmonary Fibrosis
Sydney Montesi, MD has run 4 trials for Idiopathic Pulmonary Fibrosis. Some of their research focus areas include:
Fibrosing Alveolitis
Sydney Montesi, MD has run 3 trials for Fibrosing Alveolitis. Some of their research focus areas include:
Affiliated Hospitals
Massachusetts General Hospital
Clinical Trials Sydney Montesi, MD is currently running
Collagen-targeted PET Imaging
for Interstitial Lung Disease
The goal of this study is to investigate the ability of \[68Ga\]CBP8 to detect collagen deposition in early interstitial lung disease.
Recruiting
3 awards
Phase 2
9 criteria
EGCG
for Pulmonary Fibrosis
This trial is testing EGCG, a compound from green tea, in patients with idiopathic pulmonary fibrosis (IPF). The goal is to see if EGCG can safely reduce lung scarring. EGCG works by blocking harmful signals that cause lung tissue to harden. Epigallocatechin-3-gallate (EGCG) is a polyphenol and a major component of green tea, known for its potent antioxidant, anti-inflammatory, and anti-fibrotic properties.
Recruiting
0 awards
Phase 1
11 criteria
More about Sydney Montesi, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Sydney Montesi, MD has experience with
- [68Ga]CBP8
- Placebo
- Gadoterate Meglumine
- Epigallocatechin-3-gallate (EGCG)
- N-acetyl Cysteine
- Dotarem
Breakdown of trials Sydney Montesi, MD has run
Idiopathic Pulmonary Fibrosis
Fibrosing Alveolitis
Pulmonary Fibrosis
Interstitial Lung Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sydney Montesi, MD specialize in?
Sydney Montesi, MD focuses on Idiopathic Pulmonary Fibrosis and Fibrosing Alveolitis. In particular, much of their work with Idiopathic Pulmonary Fibrosis has involved rs3570920 TT positive patients, or patients who are undergoing treatment.
Is Sydney Montesi, MD currently recruiting for clinical trials?
Yes, Sydney Montesi, MD is currently recruiting for 5 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Sydney Montesi, MD has studied deeply?
Yes, Sydney Montesi, MD has studied treatments such as [68Ga]CBP8, Placebo, Gadoterate Meglumine.
What is the best way to schedule an appointment with Sydney Montesi, MD?
Apply for one of the trials that Sydney Montesi, MD is conducting.
What is the office address of Sydney Montesi, MD?
The office of Sydney Montesi, MD is located at: Massachusetts General Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.